- $1.60bn
- $1.40bn
- $689.14m
- 74
- 20
- 90
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 301 | 374 | 503 | 618 | 689 |
Cost of Revenue | |||||
Gross Profit | 212 | 269 | 367 | 458 | 519 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 319 | 396 | 557 | 711 | 661 |
Operating Profit | -18.7 | -22.4 | -54.2 | -92.6 | 27.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.6 | -22.7 | -56.1 | -89.3 | 48.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.7 | -22.9 | -56.2 | -89.9 | 46.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.7 | -22.9 | -56.2 | -89.9 | 46.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.7 | -22.9 | -56.2 | -89.9 | 46.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.152 | -0.193 | -0.398 | -0.667 | 0.07 |